CARDIOMETABOLIC DISEASE

Clinical trials for CARDIOMETABOLIC DISEASE explained in plain language.

Never miss a new study

Get alerted when new CARDIOMETABOLIC DISEASE trials appear

Sign up with your email to follow new studies for CARDIOMETABOLIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human tests begin for new Weight-Loss drug

Disease control Recruiting now

This is an early-stage study to check if a new drug called AMG 513 is safe for people with obesity. It will involve about 80 adults and will test different doses to see how the body handles the drug. The main goal is to identify any side effects and understand how the drug behave…

Matched conditions: CARDIOMETABOLIC DISEASE

Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

CARDIOMETABOLIC DISEASE

Get alerted when new CARDIOMETABOLIC DISEASE trials appear

First human tests begin for new Weight-Loss drug